Rabeprazole Dosage
For adults, rabeprazole 20 mg once daily is the standard dose for most acid-related conditions including GERD, erosive esophagitis, and duodenal ulcers, while adolescents 12-17 years should receive 20 mg daily, and children 1-11 years require weight-based dosing of 10-20 mg twice daily depending on body weight. 1
Adult Dosing
Standard Indications
Healing of Erosive or Ulcerative GERD:
- 20 mg once daily for 4-8 weeks 1
- An additional 8-week course may be considered if healing is incomplete
Maintenance of Healed GERD:
- 20 mg once daily (controlled studies up to 12 months) 1
- Long-term PPI therapy should be titrated to the lowest effective dose based on symptom control 2
- Note: While 10 mg daily has been studied for maintenance, 20 mg daily demonstrates superior prevention of endoscopic relapse compared to 10 mg, though symptomatic relief may be equivalent at 1 year 3
Symptomatic GERD (Non-erosive):
- 20 mg once daily for up to 4 weeks 1
- Additional courses may be considered if symptoms persist
Duodenal Ulcer Healing:
- 20 mg once daily after the morning meal for up to 4 weeks 1
- Most patients heal within 4 weeks
H. pylori Eradication:
- Rabeprazole 20 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg
- All three medications twice daily with morning and evening meals for 7 days 1
Zollinger-Ellison Syndrome:
- Starting dose: 60 mg once daily, then adjust to patient needs 1
- Dosages of 100 mg once daily and 60 mg twice daily have been used
- Continue as long as clinically indicated
Administration Guidelines
- Swallow tablets whole—do not chew, crush, or split 1
- For duodenal ulcers: take after a meal
- For H. pylori eradication: take with food
- For all other indications: may take with or without food
- Optimal timing: 30-60 minutes before a meal for best acid suppression 4
Pediatric Dosing
Adolescents (12-17 years)
- 20 mg once daily for symptomatic GERD 5, 1
- Treatment duration: up to 8 weeks
- FDA-approved for this age group 1
Children (1-11 years)
Important: The 20 mg tablet strength exceeds recommended doses for children under 12 years 1. Consider another rabeprazole formulation for this age group.
Weight-based dosing recommendations for H. pylori eradication (twice daily): 6
- 6-10 kg: 10 mg twice daily
- 10-30 kg: 15 mg twice daily
- ≥30 kg: 20 mg twice daily
Infants (<1 year)
- Not recommended 5
- Placebo-controlled trials in infants have not demonstrated superiority of PPIs over placebo for reducing irritability 5
- Infants may be at increased risk of lower respiratory tract infections with PPI use 5
Special Populations
Hepatic Impairment
- Mild to moderate (Child-Pugh A and B): No dosage adjustment necessary 1
- Severe (Child-Pugh C): Avoid use; if treatment necessary, monitor closely for adverse reactions 1
Renal Impairment
- No dosage adjustment necessary 7
Geriatric Patients
- No dosage adjustment required 1
- No overall differences in safety or effectiveness observed in patients ≥65 years
Clinical Considerations
Dose Escalation for Inadequate Response: If symptoms persist after 4-8 weeks of once-daily therapy, consider:
Important Caveats:
- Rabeprazole has less CYP2C19 genetic polymorphism influence compared to other PPIs due to its non-enzymatic metabolism pathway 8, 9
- Rapid onset of action with high pKa (~5.0) allows activation at higher pH levels 8, 9
- Twice-daily dosing is recommended when once-daily therapy fails, though most clinical trial data supports once-daily dosing 2
- Patients with erosive esophagitis should receive continuous rather than on-demand therapy to prevent endoscopic relapse 2
Long-term Safety Monitoring: While generally well-tolerated, be aware of potential risks with prolonged use including community-acquired pneumonia, gastroenteritis, and enterochromaffin cell hyperplasia (observed in up to 50% of children after >2.5 years) 5